AZITRA
Live / Registered — Registered (as of 11 Jan 2022)
What this means for you
Registered since 11 Jan 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Jan 2028: the §8 declaration of use).
Record
- Serial number
- 87658797
- Registration number
- 6615607
- Mark type
- Word mark
- Filed
- 25 Oct 2017
- Published for opposition
- 25 Sept 2018
- Registered
- 11 Jan 2022
- Next maintenance filing
- §8 declaration of use, due by 11 Jan 2028 (grace period to 11 Jul 2028)
- Attorney of record
- Keith Toms, Esq.
Goods and services
- Class 042 — Scientific and technological services: Research and development of microbiome therapeutics for skin disease; scientific research in the field of microbiome therapies; research and development of therapies for skin disease; biotechnology research; scientific research and development; pharmaceutical research services; all of the foregoing excluding ocular, peri-ocular and sight * and diabetes * fields
Owner
- Azitra Inc., Branford, CT, US
- Azitra Inc., Branford, CT, US
- Azitra Inc., Farmington, CT, US
Prosecution history
- 14 Nov 2023 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 10 Oct 2023 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 02 May 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 17 Feb 2023 — POST REGISTRATION ACTION MAILED - SEC. 7
- 14 Feb 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Sept 2022 — TEAS SECTION 7 REQUEST RECEIVED
- 11 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Dec 2021 — AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
- 07 Dec 2021 — ASSIGNED TO LIE
- 06 Dec 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Nov 2021 — USE AMENDMENT FILED
- 19 Nov 2021 — TEAS STATEMENT OF USE RECEIVED
- 01 Dec 2021 — TEAS POST PUBLICATION AMENDMENT RECEIVED